Updates are available Correction dated 2024-11-13
Click to view Correction: https://doi.org/10.1007/s12519-024-00852-9
-
Authors
Dou, Cong
Yu, Yong-Hui
Zhuo, Qing-Cui
Qi, Jian-Hong
Huang, Lei
Ding, Yan-Jie
Yang, De-Juan
Li, Li
Li, Dan
Wang, Xiao-Kang
Wang, Yan
Qiao, Xin
Zhang, Xiang
Zhang, Bing-Jin
Jiang, Hai-Yan
Li, Zhong-Liang
Reddy, Simmy
-
Funding
Funding for this research was provided by:
Key Technology Research and Development Program of Shandong (2018GSF11816)
Chinese Society of Clinical Oncology (YXH2022DZX0200X)
- License Information
-
More Information
Article History
Received: 16 August 2022
Accepted: 1 December 2022
First Online: 5 January 2023
Change Date: 2 November 2024
Change Type: Update
Change Details: The original online version of this article was revised: The affiliation details for Authors Cong Dou and Yong Hui Yu were incorrectly published and have now been corrected.
Change Date: 13 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12519-024-00852-9
Declarations
:
: No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.
: The research protocol has been registered in the Chinese Clinical Trial Registration Center (ID: ChiCTR1900025234) and has been ethically reviewed by the Ethics Committee of the Provincial Hospital Affiliated to Shandong First Medical University (LCYJ: No. 2019-132). Informed consent to participate in the study have been obtained from participants’ parent.
